Actieve functies van Christopher Taylor
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Loopbaan van Christopher Taylor
Eerdere bekende functies van Christopher Taylor
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CODIAK BIOSCIENCES | Investor Relations Contact | 01-12-2020 | 01-06-2023 |
| Public Communications Contact | 01-12-2020 | 01-06-2023 | |
| ALAUNOS THERAPEUTICS, INC. | Investor Relations Contact | 01-03-2019 | - |
| Public Communications Contact | 01-03-2019 | - |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Christopher Taylor
- Ervaring
